Rethinking Health: The Future of GLP-1s
Dr. Haleem Mohammed on where GLP-1s are going, and what that means for you.
By now, you probably know someone on Ozempic or Wegovy. Maybe you're on it yourself. The GLP-1 story has been one of the biggest in medicine over the last few years, and most of the conversation has been about what these drugs do right now: weight loss, blood sugar, and a waiting list at your pharmacy.
But the more interesting conversation is what's next.
Since the beginning, the goal for Rethinking Health has been to make you smarter about the current healthcare landscape. This time, the goal is to make you smarter about what's coming.
Haleem "Dr. Hal" Mohammed is Global Chief Medical Officer of Gameday Men's Health, the largest concierge men's health network in North America, where he oversees clinical protocols for GLP-1s and compounded therapies across hundreds of clinics. He is also a board-certified internist, a physician executive with an MBA in healthcare administration, and one of the clearest communicators in the field on separating the real science from the noise. He is going to walk us through the full picture.
The conversation will cover:
Beyond weight loss: what conditions might GLP-1s treat next?
Microdosing: fringe experiment or the future standard of care?
The move from injectables to pills: how close is it, and what changes when it happens?
Compounding pharmacy peptides versus research peptides: know the difference
Long-term effects: what do we actually know .. and what don't we know?
Come for dinner. Leave knowing more than you did about one of the most consequential drug classes in a generation.
Haleem "Dr. Hal" Mohammed, MD, MBA is Global Chief Medical Officer of Gameday Men's Health, the largest concierge men's health network in North America, with over 400 clinics and 1,000 in development. A board-certified internist and award-winning physician executive, he oversees clinical governance and protocols involving GLP-1s, compounded medications, and emerging therapies across North American operations. He also serves as CEO of South Florida Wellness Group, which operates Gameday clinics across Miami-Dade, Broward, and Palm Beach counties, and holds an MBA in healthcare administration from UMass Isenberg. He was recognized as 2024 Healthcare Innovator of the Year by South Florida Business & Wealth.